Calumet, Inc.
CLMTBasic MaterialsNASDAQSpecialty Chemicals
Scan Results
Daily timeframeCalumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. With a market capitalization of $4.33B, it sits in mid-cap territory. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments.
Market Cap
$4.33B
Beta
0.78
P/E (TTM)
—
P/E (Fwd)
15.41
EPS (TTM)
$-1.55
EPS (Fwd)
$3.20
ROE
—
ROA
-1.3%
Cash
$109.8M
Total Debt
$2.37B
Free CF
$172.6M
52W Change
145.3%
Annual Financials
Cash vs Debt
Where CLMT stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, CLMT finished 34.74% above its 150-day moving average ($41.22) and 49.54% above its 200-day moving average ($37.14). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CLMT overbought or oversold?
At the October 20, 2026 close, CLMT's RSI(14) was 58.1, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, CLMT has $109.8M in cash with $2.37B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $172.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Revenue has pulled back from $4.69B (2022) to $4.14B (2025), a 12% decline worth watching.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Calumet, Inc. and its sector.